| Predicate |
Object |
| contentType |
Journal Article |
| issn |
1664-2295 |
| pageRange |
67- |
| publicationName |
Frontiers in Neurology |
| startingPage |
67 |
| bibliographicCitation |
Takayanagi K. Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin. Front Neurol. 2011;2():67. PMID: 22131983; PMCID: PMC3222848. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ea637a496db754fec68e21b57b33806 |
| date |
2011 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3222848
https://pubmed.ncbi.nlm.nih.gov/22131983
https://doi.org/10.3389/fneur.2011.00067 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1664-2295
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38589 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Prevention of Adiposity by the Oral Administration of ?-Cryptoxanthin |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281235 |